Study of the Safety and Efficacy of Intravenous Alpha-1 Antitrypsin in Type 1 Diabetes Mellitus
Clinical trial NCT01304537 · COMPLETED
Trial details
- NCT number
- NCT01304537
- Sponsor
- Kamada, Ltd.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-06-01
- Primary completion
- 2012-11-01
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.